- Home
- SOHU vs ORGO Comparison
SOHU vs ORGO Comparison
Compare SOHU & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SOHU | ORGO |
|---|---|---|
| Founded | 1996 | 1985 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 391.6M | 348.6M |
| IPO Year | 2018 | 2016 |
Fundamental Metrics
Financial Performance| Metric | SOHU | ORGO |
|---|---|---|
| Price | $13.90 | $2.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $20.00 | $8.50 |
| AVG Volume (30 Days) | 38.6K | ★ 1.3M |
| Earning Date | 05-18-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1600.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $564,169,000.00 |
| Revenue This Year | $1.61 | N/A |
| Revenue Next Year | $3.78 | $26.27 |
| P/E Ratio | $1.16 | ★ N/A |
| Revenue Growth | N/A | ★ 17.04 |
| 52 Week Low | $9.97 | $2.04 |
| 52 Week High | $17.30 | $7.08 |
Technical Indicators
Market Signals| Indicator | SOHU | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 36.09 | 55.33 |
| Support Level | N/A | $2.21 |
| Resistance Level | $16.12 | $2.66 |
| Average True Range (ATR) | 0.52 | 0.19 |
| MACD | -0.16 | 0.02 |
| Stochastic Oscillator | 14.96 | 80.55 |
Price Performance
Historical ComparisonAbout SOHU Sohu.com Limited
Sohu.com Ltd provides online media, games, and search products and services on PCs and mobile devices in China. The company operates in Sohu and Changyou segments. Sohu is an online media content and services provider. Through its social features, Sohu also enables users to generate and distribute content, as well as interact with each other on a platform. Changyou is an online game developer and operator. It generates maximum revenue from the Changyou segment.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.